XML 34 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 9 Months Ended
Feb. 28, 2014
Feb. 28, 2013
Feb. 28, 2014
Feb. 28, 2013
REVENUES        
Product revenues $ 54,623 $ 44,124 $ 159,198 $ 135,429
Service revenues 7,373 6,931 20,945 16,093
Total Revenues 61,996 51,055 180,143 151,522
COST OF REVENUES        
Cost of product revenues 26,933 20,049 76,234 61,063
Cost of service revenues 4,358 3,693 13,349 9,346
Total Cost of Revenues 31,291 23,742 89,583 70,409
GROSS MARGIN 30,705 27,313 90,560 81,113
OPERATING EXPENSES        
Sales and marketing 11,986 10,533 33,529 30,232
General and administrative 6,320 5,132 18,135 14,510
Research and development 2,106 1,982 6,496 5,901
Operating Expenses, Total 20,412 17,647 58,160 50,643
OPERATING INCOME 10,293 9,666 32,400 30,470
OTHER INCOME (EXPENSE)        
Interest income 28 33 88 114
Change in purchase consideration 0 (40) 0 (92)
Other income (expense) (68) 401 (610) 522
Nonoperating Income (Expense), Total (40) 394 (522) 544
INCOME BEFORE INCOME TAXES 10,253 10,060 31,878 31,014
INCOME TAXES 3,700 3,450 11,400 10,950
NET INCOME 6,553 6,610 20,478 20,064
NET LOSS ATTRIBUTABLE TO NON- CONTROLLING INTEREST 22 42 143 94
NET INCOME ATTRIBUTABLE TO NEOGEN CORPORATION $ 6,575 $ 6,652 $ 20,621 $ 20,158
NET INCOME ATTRIBUTABLE TO NEOGEN CORPORATION PER SHARE        
Basic $ 0.18 $ 0.19 $ 0.57 $ 0.56
Diluted $ 0.18 $ 0.18 $ 0.56 $ 0.55